This product is a human monoclonal antibody that is specific for MERS-CoV. This antibody can be used in a variety of applications, such as ELISA, WB, Neut, IHC, FC.
Figure 1 Clones were selected from the second polyclonal pool for monoclonal ELISA assay against crude rMERS-NP.
Histogram showing the absorbance of monoclonal scFv antibody phage binding against crude rMERS-NP after normalizing with background values. H5 and H11 are the positive controls, labelled as P (OD405nm readouts 3.54 and 3.90, respectively) while H6 and H12 are the negative controls, labelled as N (OD405nm readouts 0).
Lim, C. C., Woo, P. C., & Lim, T. S. (2019). Development of a phage display panning strategy utilizing crude antigens: isolation of MERS-CoV nucleoprotein human antibodies. Scientific reports, 9(1), 1-15.
Figure 2 The antibody fragments were subjected to antigen binding ELISA assay against a serial dilution of rMERS-NP(His6) at various concentrations.
The absorbance of each set of samples after normalizing with background values are presented as mean ± s.d. (n = 3) in the line graphs.
Lim, C. C., Woo, P. C., & Lim, T. S. (2019). Development of a phage display panning strategy utilizing crude antigens: isolation of MERS-CoV nucleoprotein human antibodies. Scientific reports, 9(1), 1-15.
Figure 3 The absorbance of the control set during the ELISA assay.
Lim, C. C., Woo, P. C., & Lim, T. S. (2019). Development of a phage display panning strategy utilizing crude antigens: isolation of MERS-CoV nucleoprotein human antibodies. Scientific reports, 9(1), 1-15.
Figure 4 Cross-reactivity ELISA assay of antibody fragments against other His6-tagged protein was also performed.
The control antigen used is 10 μg of rGFP(His6). The absorbance for all sample sets were collected in triplicates and presented as mean ± s.d. (n = 3) in the bar graph.
Lim, C. C., Woo, P. C., & Lim, T. S. (2019). Development of a phage display panning strategy utilizing crude antigens: isolation of MERS-CoV nucleoprotein human antibodies. Scientific reports, 9(1), 1-15.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-4106 | Hi-Affi™ Recombinant Rabbit Anti-MERS-CoV Monoclonal Antibody (SI177DS) | ELISA, IHC-P, ICC/IF, IF, FC | IgG |
MOR-4453 | Hi-Affi™ Recombinant Rabbit Anti-MERS-CoV Monoclonal Antibody (SI546DS) | MN | IgG |
There are currently no Customer reviews or questions for FAMAB-0620WJ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.